Condition: Carcinoma, Non-Small-Cell Lung · Sponsor: Merck Sharp & Dohme LLC
Researchers are looking for new ways to treat people with locally advanced non-small cell lung cancer (NSCLC). The goal of this study is to learn if people who receive the combination of vibostolimab and pembrolizumab (MK-7684A) live longer without the cancer getting worse and live longer overall than people who receive durvalumab.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| VA Long Beach Healthcare System ( Site 2831) | Long Beach, California, United States | — |
| VA West Los Angeles Medical Center ( Site 2808) | Los Angeles, California, United States | — |
| Millennium Oncology Research Clinic ( Site 2801) | Hollywood, Florida, United States | — |
| Mid Florida Hematology and Oncology Center ( Site 2800) | Orange City, Florida, United States | — |
| Moffitt Cancer Center ( Site 2818) | Tampa, Florida, United States | — |
| University of Chicago Medical Center ( Site 2828) | Chicago, Illinois, United States | — |
| Franciscan St. Francis Health ( Site 2812) | Indianapolis, Indiana, United States | — |
| MFSMC-HJWCI ( Site 2804) | Baltimore, Maryland, United States | — |
| Boston Medical Center ( Site 2829) | Boston, Massachusetts, United States | — |
| University of Massachusetts Chan Medical School ( Site 2815) | Worcester, Massachusetts, United States | — |
| University of Missouri Hospital ( Site 2839) | Columbia, Missouri, United States | — |
| Cox Medical Center North-Cox Medical Center/Hulston Cancer Center/ Radiation Oncology ( Site 2837) | Springfield, Missouri, United States | — |
+ 148 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.